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Catalytically Active Lysine with g-Thialysine by Using
a Chemical Mutagenesis Strategy
Nicole Timms,[a, b] Claire L. Windle,[a, b] Anna Polyakova,[a, b] James R. Ault,[a, b] Chi H. Trinh,[a, b]
Arwen R. Pearson,[a, b] Adam Nelson,[a, c] and Alan Berry*[a, b]
Introduction
Enzymes are typically built of the 20 proteogenic amino acids
and are phenomenally powerful catalysts that may increase re-
action rates over 1018-fold.[1, 2] Their catalytic function stems
from the range of side-chain chemistries available which can
be supplemented by the ability to bind and recruit metal ions
or other cofactors. However, in some cases, nature has expand-
ed the catalytic repertoire of enzymes by using noncanonical
amino acids incorporated into the polypeptide chain, either by
genetic encoding (such as selenocysteine[3] and pyrrolysine[4])
or by post-translational modifications. Examples of catalytically
important residues incorporated by post-translational modifica-
tions include the quinone cofactors such as 2,4,5-trihydroxy-
phenylalanine quinone (TPQ) in amine oxidase, lysyl tyrosylqui-
none (LTQ) in lysyl oxidase and tryptophan tryptophylquinone
(TTQ) in methylamine dehydrogenase,[5, 6] formylglycine in the
type I sulfatases,[7] 4-methylidene imidazole-5-one (MIO) in
aminomutases[8] and the N-terminal pyruvoylphenylalanine in
yeast histidine decarboxylase.[6] Protein engineers have exploit-
ed rational site-directed mutagenesis and directed evolution to
alter many properties of enzymes including their specificity,
stability and stereochemistry.[9, 10] More recently computer-
aided enzyme design, coupled with directed evolution has
made significant advances in opening the way to new designer
enzymes.[11–13] However these approaches have remained limit-
ed to the use of the 20 proteogenic amino acids.
Two methods have recently been developed that enable the
synthetic biologist to use unnatural amino acids to construct
novel enzyme active sites: one using the ribosome in conjunc-
tion with new, orthogonal tRNA/tRNA synthetase (tRNAS)
pairs[14,15] and the other, using chemical modification, to intro-
duce new amino acid side chains.[16] The use of orthogonal
Chemical modification has been used to introduce the unnatu-
ral amino acid g-thialysine in place of the catalytically impor-
tant Lys165 in the enzyme N-acetylneuraminic acid lyase (NAL).
The Staphylococcus aureus nanA gene, encoding NAL, was
cloned and expressed in E. coli. The protein, purified in high
yield, has all the properties expected of a class I NAL. The
S. aureus NAL which contains no natural cysteine residues was
subjected to site-directed mutagenesis to introduce a cysteine
in place of Lys165 in the enzyme active site. Subsequently
chemical mutagenesis completely converted the cysteine into
g-thialysine through dehydroalanine (Dha) as demonstrated by
ESI-MS. Initial kinetic characterisation showed that the protein
containing g-thialysine regained 17% of the wild-type activity.
To understand the reason for this lower activity, we solved X-
ray crystal structures of the wild-type S. aureus NAL, both in
the absence of, and in complex with, pyruvate. We also report
the structures of the K165C variant, and the K165-g-thialysine
enzyme in the presence, or absence, of pyruvate. These struc-
tures reveal that g-thialysine in NAL is an excellent structural
mimic of lysine. Measurement of the pH-activity profile of the
thialysine modified enzyme revealed that its pH optimum is
shifted from 7.4 to 6.8. At its optimum pH, the thialysine-con-
taining enzyme showed almost 30% of the activity of the
wild-type enzyme at its pH optimum. The lowered activity and
altered pH profile of the unnatural amino acid-containing
enzyme can be rationalised by imbalances of the ionisation
states of residues within the active site when the pKa of the
residue at position 165 is perturbed by replacement with g-
thialysine. The results reveal the utility of chemical mutagene-
sis for the modification of enzyme active sites and the exqui-
site sensitivity of catalysis to the local structural and electro-
static environment in NAL.
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tRNA/tRNAS pairs has found growing use,[17] but the yields of
recombinant protein containing the unnatural amino acid can
be disappointing. In contrast, expression of the natural poly-
peptide chain may yield high levels of protein, but the low effi-
ciency[18] and lack of specificity[19] of many chemical modifica-
tion strategies limits their usefulness. In 1966, Koshland noted
the use of dehydroalanine (Dha) in “chemical mutagenesis”[20]
and recently Chalker and Davis have devised an efficient
double alkylation-elimination method to generate Dha in an
enzyme and convert it to an unnatural amino acid
(Scheme 1).[16]
Here we use this method[16] to convert the catalytically es-
sential lysine of the enzyme N-acetylneuraminic acid lyase
(NAL) to generate a nonproteogenic amino acid and we ana-
lyse the resulting enzyme to explain the structural origins and
basis of its catalytic activity.
NAL catalyses the reversible aldol condensation of N-acetyl-
mannosamine with pyruvate to yield the sialic acid, N-acetyl-
neuraminic acid (Neu5Ac). We have previously shown the
E. coli enzyme to be an attractive target for rational protein en-
gineering and directed evolution.[21–23] NAL is a class I aldolase,
functioning through the formation of an enzyme–pyruvate
Schiff base formed with Lys165 which carries out a nucleophilic
attack on the aldehyde carbon of the open-chain form of the
N-acetylmannosamine (Scheme 1).[24] Here, using the NAL from
Staphylococcus aureus, we demonstrate quantitative conver-
sion of a cysteine residue, site-specifically into the nonproteo-
genic amino acid g-thialysine, chosen as a mimic of the natural
catalytic lysine residue at position 165, using the double alkyla-
tion-elimination method[16] and that high yields of an active,
modified NAL can be purified. We then characterise the result-
ing enzyme activity, analyse the pH-dependency of catalysis
and use X-ray crystallography to investigate the structural
basis of the changes brought about by modifying the enzyme.
These results open the way to the construction of novel aldo-
lase active sites containing unnatural amino acids for new
chemistries.
Results and Discussion
The chemical insertion of a nonproteogenic amino acid into
the active site of NAL requires the conversion of a cysteine res-
idue into dehydroalanine followed by conjugate addition of a
thiol to generate the new amino acid side chain (Scheme 1).[16]
Initial work on the E. coli NAL revealed that removal of the four
natural cysteine residues in the enzyme (Cys82, Cys118, Cys238
and Cys270) by mutagenesis to either serine or alanine resi-
dues produced enzymes with kinetic properties identical with
the wild-type enzyme (see Table S1 in the Supporting Informa-
tion). Subsequent mutation of Lys165 to a cysteine residue,
produced an enzyme with only low activity, as expected, but
this mutant enzyme was unsuitable for chemical modification
because of its poor long-term solubility, slowly precipitating
over a period of 1–2 days. We therefore scanned the protein
sequence databases for natural, cysteine-free, NAL enzymes. A
putative sequence from S. aureus was identified (Uniprot acces-
sion number Q2G160) and we amplified the gene (nanA) by
PCR (Table S2) and cloned it into the expression vector
pKK223-3. After induction of protein expression with IPTG,
a band of 34 kDa was seen on SDS-PAGE corresponding to the
size of protein expected from the DNA sequence. The protein
was purified using a His6 tag appended to the N terminus of
the protein, in the same manner as used previously for the
E. coli enzyme.[22] The purified protein was shown to have NAL
Scheme 1. Mechanism and chemical modification of N-acetylneuraminic acid lyase. A) The enzymatic reaction mechanism showing the involvement of Lys165
in forming the pyruvate Schiff base. B) The scheme for the chemical modification[16] to introduce unnatural amino acids through dehydroalanine illustrated by
the conversion of Lys165 to g-thialysine. Molecular masses shown illustrate the expected masses for modification of the S. aureus NAL.
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activity and the kinetic parameters determined were similar to
those of the E. coli NAL (Table 1). Positive mode ESI-MS of the
enzyme identified its molecular mass as 339920.48 Da, in
agreement with the expected mass calculated from the amino
acid sequence (33995 Da).
A mutant nanA gene encoding the K165C S. aureus NAL was
created using site-directed mutagenesis and DNA sequencing
confirmed the presence of the mutation. The variant protein
was expressed and purified in the same manner as the wild
type. The steady-state parameters for Neu5Ac cleavage
showed that the K165C variant was severely impaired in cataly-
sis (kcat/Km reduced 720-fold compared with wild-type; Table 1)
as would be expected for the removal of the catalytically im-
portant Schiff-base-forming residue, and in line with similar
studies on other class I aldolases.[18]
Chemical modification of K165C to yield g-thialysine
The purified K165C NAL was chemically modified to introduce
the new side chain at position 165. Experiments demonstrated
that the cysteine side chain in the native protein was inaccessi-
ble to the reagent 2,5-dibromo-1,6-hexadiamide used to gener-
ate the dehydroalanine residue. The protein was thus unfolded
in 6m urea prior to treatment with 2,5-dibromo-1,6-hexadi-
amide for 1.5 h at 37 8C. Under these conditions a double alky-
lation reaction followed by elimination takes places to gener-
ate K165Dha (Scheme 1B). An ESI mass spectrum taken after
1.5 h revealed a single protein species of molecular mass
339340.63 Da, exactly as expected for the K165Dha variant
(33934 Da, Figure 1), demonstrating the quantitative conver-
sion of Cys165 to dehydroalanine (Dha165).
The dehydroalanine side chain was next converted into g-
thialysine by conjugate addition of 2-aminoethanethiol onto
the K165Dha protein. Analysis by ESI-MS after two hours incu-
bation of the enzyme with 2-aminoethanethiol revealed quan-
titative conversion of K165Dha into a single peak correspond-
ing to a protein of 340120.16 Da, in excellent agreement
with that expected for the K165-g-thialysine enzyme (expected
mass 34012 Da). The incorporation of the modification at posi-
tion 165 was also confirmed by peptide sequencing using LC-
MS/MS after tryptic digestion of the protein (see Figure S4).
The K165-g-thialysine enzyme was then refolded by dialysis
under conditions shown to regenerate 100% of native activity
for refolding of the denatured
wild-type enzyme (Figure 2A
and C). Following refolding, the
K165-g-thialysine enzyme re-
gained significant activity com-
pared with the K165C variant
(Table 1) Using this method up
to 50 mg of enzyme was suc-
cessfully modified.
The regain of approximately
10% of the wild-type activity
(based on kcat/Km values) upon
replacement of a catalytic lysine
residue with g-thialysine is in
line with reports of similar replacements carried out previously
by direct alkylation of an introduced cysteine at the site of cat-
alytic lysine residues.[18,25–28] However in a number of those
cases the low activity recovered was explained by incomplete
conversion. Here, the lower kcat values for the K165-g-thialy-
Table 1. Steady-state kinetic parameters of wild-type and variant S. aureus NAL. Steady-state kinetic parameters
for the cleavage of N-acetylneuraminic acid (Neu5Ac) by wild-type and variant S. aureus NAL determined using
an LDH-coupled enzyme assay.[22, 38] Data were fitted to the Michaelis–Menten equation and the fitted values
standard error of the fit are shown.
Enzyme pH Km (Neu5Ac) kcat kcat/Km % of pH 7.4
(assay pH) [mm] [min1] [min1mm1] wild-type kcat/Km
wild type 7.4 2.20.1 2505 114 100
K165C 7.4 0.80.1 0.080.004 0.1 0.09
K165-g-thialysine pre-gel-filtration 7.4 0.70.05 80.1 11 10
gel-filtered K165-g-thialysine 7.4 1.40.2 260.9 19 17
wild type 6.8 2.40.2 2606 108 95
gel-filtered K165-g-thialysine 6.8 0.90.09 290.8 32 28
Figure 1. Deconvoluted ESI-mass spectra of A) the K165C variant of S. aureus
NAL, B) the K165C variant after 1.5 h treatment with 2,5-dibromo-1,6-hexa-
diamide, the mass found (339340.63 Da) corresponds exactly with that ex-
pected (33934 Da) for the K165Dha enzyme, and C) the K165Dha enzyme
after reaction with 2-aminoethanethiol to generate the K165-g-thialysine
enzyme. The molecular mass found (340120.16 Da) corresponds exactly
with that expected (34012 Da) for the chemically modified enzyme. (See Fig-
ure S3 for m/z spectra).
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sine-containing enzyme cannot be explained by incomplete
conversion of K165Dha since there is no evidence of K165Dha
or unmodified enzyme in the ESI-mass spectrum. We therefore
sought further evidence to evaluate whether structural differ-
ences between NAL containing lysine or g-thialysine at posi-
tion 165 might be responsible for the lower activity of the
chemically modified enzyme. As a prelude to X-ray crystallo-
graphic studies we further purified the chemically modified g-
thialysine-containing NAL by gel filtration. Unlike the wild-type
S. aureus NAL, the chemically modified protein eluted in two
peaks: one active fraction at the elution volume expected for
a protein of approximately 34 kDa; and another at the void
volume of the column, due to aggregated protein. Removal of
this material resulted in an approximate doubling of the specif-
ic activity of the modified enzyme, to 17% (based on kcat/Km
values) of the activity of the wild-type enzyme (Table 1) and
far-UV CD spectroscopy suggests that the modified enzyme
was correctly folded as its spectrum is identical to that of the
wild-type enzyme (Figure 2B).
Crystallographic studies
The wild-type S. aureus NAL was crystallised and the structure
solved using molecular replacement methods (PDB ID: 4AHP).
In addition, the structure of the enzyme–pyruvate complex
(PDB ID: 4AH7) was also determined. Finally, we solved the
structure of the K165C variant (PDB ID: 4AHQ), and the K165-g-
thialysine enzyme with (PDB ID: 4AMA), and without (PDB ID:
4AHO) bound pyruvate. All structures were solved in space
group P212121 (see Table S5 for structural data).
The crystal structure of the S. aureus NAL shows that the
enzyme adopts a TIM-(b/a)8-barrel tertiary structure identical
to that previously observed for the E. coli (PDB ID: 2WO5)[29]
and Haemophilus influenzae (PDB ID: 1F5Z)[30] NALs, with RMSD
values of 1.36 and 0.84  for alignments of the subunit alpha-
carbons of the S. aureus structure with the E. coli and H. influ-
enzae enzymes, respectively. Comparison of the E. coli (PDB ID:
2WNN)[29] and S. aureus (4AH7) enzymes in complex with pyru-
vate showed that the pyruvate is covalently linked to the
enzyme as a Schiff base and makes identical interactions with
the backbone amides of Ser48 and Ser49 and also with the
side-chain hydroxyl group of Ser49 (equivalent to Ser47 and
Thr48 in the E. coli enzyme; Figure 3A and B). The effect of
Schiff base formation in the S. aureus enzyme is also similar to
that found with the E. coli enzyme, namely that it causes order-
ing of the loop region (138–146) which is not resolved in apo
structures. This results in a repositioning of Tyr137, a residue
noted as being involved in substrate stabilisation and/or catal-
ysis.[31]
The structure of the K165C variant showed no significant
changes in the overall structure of the protein compared with
the wild-type enzyme (RMSD over all Ca atoms=0.34 ). How-
ever, the observed electron density for residue 165 did not
extend far enough for a lysine residue and was better fitted by
a cysteine residue (Figure 3C) as expected. Interestingly, the
K165C structure more closely resembled the enzyme–pyruvate
complexes than the apo structures since the loop region (138–
146), not generally resolved in apo structures, could be clearly
seen in the structure of the K165C variant and the side chain
of Tyr137 was also positioned more similarly to that in the pyr-
uvate complexes (Figure 3C). Calculation of side-chain solvent
accessibility for the K165C variant showed that the cysteine is
inaccessible explaining the need to unfold the protein prior to
chemical modification. Despite soaking K165C crystals with up
to 100 mm pyruvate, we were never able to observe electron
density for substrate in the enzyme active site.
The 3D structure of the K165-g-thialysine enzyme was
solved at 2  resolution. Initial modelling of Lys165 in all four
subunits revealed a strong positive electron density around
the gamma carbon of the side chain of residue 165, thus indi-
cating the presence of a more electron-dense atom. Subse-
Figure 2. Refolding of S. aureus NAL after denaturation in urea. A) S. aureus
NAL (2 mgmL1) was treated with various concentrations of urea in Tris·HCl
buffer (50 mm, pH 7.4) and the activity was measured (dark bars). The urea
in the sample was then rapidly diluted tenfold with the same buffer and ac-
tivity was measured again after 10 min (light grey bars). 983% of the
wild-type activity is recovered after tenfold dilution from 6m urea. Similar re-
sults were found if rapid dilution is replaced by dialysis in the same buffer
(data not shown). B) Far-UV CD spectra of wild-type S. aureus NAL (red) ; re-
folded wild-type NAL (orange); thialysine-165-containing NAL before gel fil-
tration (dark green) and gel-filtered thialysine-165 NAL (light green). C) The
kinetic parameters determined at pH 7.4 for wild-type S. aureus NAL before
and after refolding.
 2013 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim ChemBioChem 2013, 14, 474 – 481 477
CHEMBIOCHEM
FULL PAPERS www.chembiochem.org
quent replacement with g-thialysine side chains correctly ac-
counted for this density in the FobsFcalcd map and showed the
presence of g-thialysine in all four subunits of the enzyme (Fig-
ure 3D). The chemical modification of the enzyme has not al-
tered its overall fold. Alignment of all of the Ca atoms of the
K165-g-thialysine structure with the wild-type structure result-
ed in an RMSD value of only 0.13 . Interestingly, the crystal
structure of modified enzyme showed no evidence of d-thialy-
sine at position 165. This is despite the fact that the thialysine
side chain is generated by Michael addition onto the planar
dehydroalanine which, in model peptides[32] at least, can result
in thiol attack onto either face of the double bond producing
a mixture of d- and l-modified amino acids. Since burial of res-
idue 165 in the S. aureus NAL active site necessitated unfolding
of the enzyme in 6m urea in order that modification could
take place, it is likely that a mixture of d- and l-thialysine-
modified NAL will be generated, although residual structure in
the unfolded state and the chiral nature of the polypeptide
backbone might impose some steric constraints on the modifi-
cation reaction. We hypothesise therefore that both stereoiso-
mers are formed but that the d-thialysine-modified protein
does not correctly refold, and is removed by the gel-filtration
step.
The positioning of the nitrogen atom in lysine/g-thialysine-
165 may be crucially important for the catalytic ability of the
enzyme. The g-thialysine residue is found to be in a fully ex-
tended anti configuration within the active site, as is observed
with Lys165 in the wild-type enzyme. However the presence of
the sulfur atom in the g-thialysine side chain alters both the
bond lengths around the gamma atom of the residue and the
bond angles of the side chain. In the wild-type enzyme the
average CbCg and CgCd bond lengths in Lys165 in the four
polypeptide chains in the tetramer are both 1.5  and the Cb
CgCd bond angle is 110.18, in excellent agreement with the
values of 1.53 , 1.54  and 110.08 found in free lysine.[33] The
average CbSg and SgCd bond lengths in the four g-thialy-
sines in the tetramer are 1.8  and the CbSgCd bond angle
is 97.28 (compared with 1.82 , 1.81  and 102.98 in free g-thia-
lysine[34]). These changes result in the overall “length” of the
residue at position 165 (as measured by the Ca-NZ distance)
increasing from 6.1  for Lys165 to 6.4  for g-thialysine-165.
Therefore the amino group of the residue at position 165 is
moved only approximately 0.3  towards the central axis of
the (b/a)8-barrel of the enzyme, due to the increased bond
lengths in thialysine, counteracted by the tighter CbSgCd
bond angle.
Soaking the crystals of K165-g-thialysine NAL with 100 mm
pyruvate allowed the structure of the pyruvate complex of this
enzyme to be solved (Figure 3E). There was clear continuous
electron density at the 1.5s level linking the residue at posi-
tion 165 with the pyruvate, revealing that the unnatural g-thia-
lysine side chain is able to form a Schiff base with the pyruvate
as part of the catalytic cycle. In this complex the pyruvate
makes identical contacts with the enzyme as in the wild-type–
pyruvate complexes; Tyr137 adopts the substrate-bound con-
formation, and the loop 138–146 becomes ordered (Figure 3E).
In all these aspects this modified enzyme behaves as the
wild-type enzyme and the active-site geometry is virtually
identical with that of the wild-type–pyruvate complex. Gross
geometric constraints or structural alterations therefore cannot
account for the difference in enzyme activity between the g-
thialysine-165 enzyme and the wild type. As well as the slight
structural alterations imposed by the chemical modification of
the side chain, the inclusion of a sulfur atom in g-thialysine
affects the pKa of the amino group of the residue, lowering its
pKa by about 1.15 pH units when compared with lysine.
[35] To
Figure 3. X-ray crystal structures of active-site residues of wild-type and chemically modified S. aureus NAL. A) Wild-type apoenzyme (4AHP). B) The Schiff
base of Lys165 with pyruvate (4AH7). The pyruvate carboxylate group interacts with the backbone amides of Ser48 and Ser49 and the side-chain hydroxyl
group of Ser49, identical to the interactions with Ser47 and Thr48 previously seen in the pyruvate complex of the E. coli enzyme.[29] C) The structure of the
active site of the K165C enzyme (4AHQ). D) The active site of the g-thialysine-165 enzyme (4AHO). E) The structure of the Schiff base formed between pyru-
vate and g-thialysine at position 165 in the chemically modified enzyme (4AMA). The carboxylate makes the same interactions as for the wild-type S. aureus
enzyme. In all cases the structure of subunit A of the tetramer is illustrated and electron density around residue 165 is mapped at the 1.4s level. In each case
the atoms are coloured by atom type with the carbon atoms coloured green in the wild-type structure, cyan in the wild-type pyruvate complex, purple in the
K165C structure, yellow in the thialysine-containing NAL and salmon in the thialysine-NAL–pyruvate complex.
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investigate how changing the pH of the enzyme assay affects
the activity of the thialysine-165 variant, we measured the pH-
activity profile of both wild-type and thialysine-containing
S. aureus NAL. The pH profile for the wild-type S. aureus
enzyme (Figure 4A and Figures S6 and S7) shows a typical
bell-shaped profile with a pH optimum of 7.4 and two pKa
values of 5.8 and 8.7. Since these apparent pKa values are
almost 3.5 pH units apart the theoretical maximum kcat/Km
value (obtained from the fit of the data) of 116 min1mm1
aligns well with the kcat/Km value measured (at pH 7.4) for the
wild-type enzyme of 114 min1mm1 (Table 1). It has not been
possible to identify residues responsible for these pKa values.
The active site of the enzyme contains a predominance of tyro-
sine residues among those side-chains which are ionisable but
despite the fact that many of these residues are predicted by
PROPKA[36] to have pKa values significantly shifted from that of
free tyrosine, none correspond exactly to the experimentally
determined values.
The pH profile for the g-thialysine-165 NAL is significantly
different to that of the wild-type enzyme (Figure 4B). The pro-
file is narrower and has a pH optimum at approximately
pH 6.8, lower than the value of 7.4 found for the wild-type
enzyme. Fitting the data to the standard bell-shaped pH profile
reveals two apparent pKa values, of 6.84 and 7.12, and a theo-
retical maximum value of kcat/Km of 71 min
1mm1. In cases
where the two pKa values are less than 3.5 pH units apart, the
theoretical maximum kcat/Km value is never observed since the
enzyme is never fully in the correct ionisation state. At its pH
optimum of 6.8, the observed kcat/Km value of thialysine-con-
taining NAL is 32 min1mm1 (Table 1), demonstrating a recov-
ery of approximately 30% of the wild-type activity. Analysis of
the theoretical titration curves for an enzyme with two active
site residues with pKa values of 6.84 and 7.12 shows that only
about 33% of the enzyme would be in the active form at the
pH optimum (see Figure S7). This suggests that the thialysine-
containing active site is perfectly primed for catalysis, but that
the microenvironment around the active site has been per-
turbed by the introduction of the thialysine side chain such
that the pKa values of various active site residues are unbal-
anced and the full power of catalysis cannot be realised.
Overall, the work described demonstrates the powerful utili-
ty of using chemical mutagenesis to derive enzymes with un-
natural catalytic side chains. Furthermore, it demonstrates that
active enzymes can be easily produced and assayed in such
a way that screening libraries of NAL with unnatural amino
acids at a variety of locations within the active site is a feasible
proposition. From a practical perspective the chemical muta-
genesis strategy requires an enzyme with a single cysteine resi-
due and, ideally, one that is solvent exposed for ease of modifi-
cation. However we have demonstrated that denaturation,
followed by chemical modification and refolding is a viable
means to generate large quantities of active, unnatural amino
acid bearing variants of NAL in sufficient yields for detailed
kinetic and structural studies. For the NAL enzyme described
here, crystallography reveals alignment of the new catalytic
thialysine in the enzyme active site placed in a conformation
set up for efficient catalysis. However, the thialysine-containing
enzyme does not recover full activity, because the introduction
of the sulfur atom in the new residue unbalances the ionisa-
tion environment of the active site such that only 33% of the
enzyme is in the correct state for catalysis to occur. Neverthe-
less, replacement of the natural lysine side chain with a thialy-
sine residue is still consistent with activity and the rate of the
reaction is enhanced 360-fold when compared with the in-
active K165C variant.
The procedure developed enables the facile production of
new NAL enzymes that can contain a repertoire of novel
amino acid side chains at position 165 that is almost limitless.
Compared with the limitations of mutagenesis, chemical strat-
egies involving dehydroalanine modification are now able to
reach their full potential as predicted by Koshland more than
45 years ago. This in turn unlocks the potential, outlined by
Brustad and Arnold[37] for the protein engineer to combine the
use of unnatural amino acids with the power of directed evolu-
tion to expand the realm of catalysis and improve protein fit-
ness for functionality to areas not available to nature.
Experimental Section
Cloning and mutagenesis: The nanA gene was amplified from
S. aureus NCTC 8325 genomic DNA (0.1 ngmL1) by PCR with Pfu
polymerase using primers designed to incorporate a His6 tag at the
Figure 4. pH profiles of kcat/Km values for NAL activity of A) wild-type
S. aureus NAL, and B) 165-g-thialysine NAL. Kinetic parameters were mea-
sured for the enzymes using the standard NAL assay[22, 38] at 30 8C in a three
component buffer system.[39] The data are fitted to bell-shaped pH profiles.
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N terminus of the protein and including EcoRI and PstI restriction
sites to allow subcloning (see Table S2 for primer sequences). The
PCR product of around 900 bp was gel purified, restricted with
EcoRI and PstI and ligated into pKK223-3 (Pharmacia) cut with the
same enzymes. The resulting expression vector was designated
pKSAnanA. Site-directed mutagenesis was carried out using Quik-
Change Lightning or QuikChange multisite-directed mutagenesis
kits (Stratagene, UK) according to the manufacturer’s guidelines.
Primers were designed by using the recommended QuikChange
Primer Design Program (Stratagene, UK).
Expression and purification of NAL: Wild-type and variant E. coli
NAL were expressed from the plasmid pKnanA-His6 as previously
described.[22] S. aureus NAL (wild-type and variants) was expressed
from E. coli BL21 (DE3) cells transformed with the plasmid
pKSAnanA harbouring the wild-type or mutant S. aureus NAL gene,
by using the method previously described.[22] Cells were grown in
2YT medium (5 mL) containing ampicillin (50 mgmL1) and inocu-
lated into 2YT medium (2 L) containing ampicillin (50 mgmL1) and
IPTG (0.4 mm) and grown for 16 h at 37 8C. Cells were lysed in a
Cell Disruption Systems apparatus at 19000 psi in Tris·HCl (50 mm,
pH 7.4), imidazole (20 mm) and NaCl (0.5m). The lysed cells were
then centrifuged at 12000g for 40 min. The supernatant, contain-
ing the soluble protein fraction, was transferred onto nickel-loaded
chelating sepharose fast flow resin (10 mL) in a 50 mL Falcon tube.
The resin was gently agitated for 20 min at 4 8C to allow the His6-
tagged protein to bind. Centrifugation (4000g, 7 min) yielded the
load supernatant, which was removed. The resin was then washed
by the addition of washing buffer [Tris·HCl (50 mm, pH 7.4), imida-
zole (20 mm), NaCl (0.5m)] . After thorough mixing the resin was
centrifuged at (4000g, 7 min) and the supernatant removed, and
this process was repeated a further three times. Elution buffer [20–
30 mL, Tris·HCl (50 mm, pH 7.4), imidazole (0.5m), NaCl (0.5m)] was
then added to the resin, after a 1 h incubation period (with agita-
tion at 4 8C) this was separated from the resin by centrifugation
(4000g, 7 min), yielding the purified protein in the supernatant.
The eluted protein was then dialysed against Tris·HCl buffer
(20 mm, pH 7.4). Further purification was achieved by size-exclu-
sion chromatography using an S-200 gel-filtration column (GE
Healthcare Life Sciences) in the same buffer before concentration
and storage. Protein purity was assessed by SDS-PAGE, and molec-
ular weight was confirmed with ESI-MS. The purified enzymes were
usually stored as lyophilised powders before chemical modifica-
tion.
Kinetic analyses: Kinetic parameters of the aldol cleavage reaction
were determined at 30 8C using a standard coupled assay[22, 38] with
lactate dehydrogenase (LDH) and NADH. The reaction (1 mL final
volume) contained varying volumes (2–300 mL) of substrate
[Neu5Ac, 100 mm in Tris·HCl (50 mm, pH 7.4)], LDH (0.5 units),
NADH (0.2 mm) and Tris·HCl (50 mm, pH 7.4). NAL samples, in
Tris·HCl (50 mm, pH 7.4), were added in volumes of 10–200 mL. The
decrease in absorbance at 340 nm was recorded on a Uvikon 930
spectrophotometer as the measure of enzyme activity. The rate of
substrate cleavage was calculated using a molar extinction coeffi-
cient of NADH of 6220m1cm1. Kinetic parameters were estimated
by fitting the data to the Michaelis–Menten equation.
The pH-activity profiles of the wild-type and K165-g-thialysine
S. aureus NAL were obtained at 30 8C using the same assay but
with an acetic acid/MES/Tris three-component buffering system
covering the pH range 4–9 whilst maintaining a constant ionic
strength.[39] Steady-state parameters were measured by fitting the
data to the Michealis–Menten equation. The values of kcat/Km
against pH were then fitted to a standard bell-shaped curve by
using the equation:

kcat
Km

obs
¼
ðkcat=KmÞmax
1þ 10pKa1pH þ 10pHpKa2
Mass spectrometry: Samples were prepared using PD10 desalting
columns and then analysed in acetonitrile/1% aq. formic acid
(50:50 v/v) by nano-electrospray ionisation MS using a quadrupole-
ion mobility spectrometry-orthogonal time-of-flight spectrometer
(Synapt HDMS, Waters, Manchester, UK). The MS was operated in
positive TOF “V” mode using a capillary voltage of 1.2 kV, cone
voltage of 50 V, nano-electrospray nitrogen gas pressure of 0.1 bar
and backing pressure of 1.78 mbar. The source and desolvation
temperatures were set at 80 8C and 150 8C, respectively. Nitrogen
was used as buffer gas at a pressure of 8.0103 mbar in the trap
and transfer regions and 3.6104 mbar in the ion mobility cell.
Mass calibration was performed by a separate injection of sodium
iodide at a concentration of 2 mgmL1 in acetonitrile/water (50:50
v/v). Data processing was performed using the MassLynx v4.1 suite
of software supplied with the mass spectrometer.
Chemical modification of K165C to yield g-thialysine: Lyophilised
K165C S. aureus NAL (2.5 mg) was dissolved in of prewarmed
(37 8C) sodium phosphate buffer, (1.25 mL, 50 mm, pH 8.0) contain-
ing urea (6m). A solution of 2,5-dibromo-1,6-hexadiamide (diBr,
synthesised as described;[16] 0.13 mgmL1, 97 mL) in DMF was
added to the protein, and was mixed immediately using a vortex
mixer for 30 s. The protein/diBr solution was incubated for 1.5 h at
37 8C, with agitation at 200 rpm. An aliquot (70 mL) was then de-
salted into ammonium acetate buffer (20 mm, pH 7.0), and ana-
lysed by ESI-MS to ensure complete conversion of K165C into
K165Dha. The conjugate addition of 2-aminoethanethiol onto the
K165Dha protein was then carried out on the unfolded K165Dha
NAL. A solution of 2-aminoethanethiol (0.1 mgmL1, 40 mL) in
Tris·HCl buffer (1.5m, pH 8.8) was added to K165Dha NAL
(2 mgmL1, 1 mL) and was incubated for 2 h at 37 8C, with agita-
tion at 200 rpm. ESI-MS was used to check for complete conversion
of Dha to the g-thialysine. For determining the pH-activity profile
for the thialysine-containing NAL, the above procedure was scaled
up so that 50 mg of enzyme was modified.
Protein refolding: Refolding of the modified enzyme was carried
out in two stages. The modified protein was first dialysed into
Tris·HCl buffer (50 mm, pH 7.4) containing urea (6m) to remove
excess modification reagents, followed by dialysis into the same
buffer in the absence of urea to refold the enzyme. Size-exclusion
chromatography was performed using an KTA Prime purification
system (GE Healthcare Life Sciences) with a Superdex S200 column.
Protein (8 mgmL1, 5 mL) was injected onto the column which was
run at 2 mLmin1.
Circular dichroism: CD spectra were obtained at room tempera-
ture using a Chirascan CD spectrometer (Applied Photophysics,
Leatherhead, UK). All spectra were recorded in a quartz cuvette
with path length 1.0 mm. Protein samples were prepared in
sodium phosphate buffer (50 mm, pH 8.0) with or without urea
(6m).
Protein crystallisation: Crystallisation conditions for the E. coli NAL
had been previously established[29] and these were used to crystal-
lise the S. aureus NAL. Crystals were grown at 18 8C by hanging
drop vapour diffusion. A ratio of 2 mL of protein (8 mgmL1) to
2 mL mother liquor was used. The crystallisation conditions were
Tris·HCl (100 mm, pH 7.0–8.5), NaCl (200 mm) and 18–28% (w/v)
poly(ethylene glycol) (PEG) 3350.
 2013 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim ChemBioChem 2013, 14, 474 – 481 480
CHEMBIOCHEM
FULL PAPERS www.chembiochem.org
To form the pyruvate complexes of the wild-type and K165-g-thia-
lysine S. aureus NALs crystals were soaked in the mother liquor
containing sodium pyruvate (100 mm) and 15% (v/v) PEG 400 for
1 min before being sequentially transferred to mother liquor with
5% increments in PEG 400 concentration. The final soak contained
the mother liquor containing sodium pyruvate (100 mm) and 25%
(v/v) PEG 400. Crystals were then flash-cooled in liquid nitrogen
prior to data collection.
Data collection and refinement: Diffraction data for all structures
were collected from single crystals at the Diamond Light Source
macromolecular crystallography beam lines I02 and I04-1. The tem-
perature for data collection was 100 K. Integration and scaling of
data was carried out by MOSFLM[40] and SCALA.[41] The structure of
the wild-type S. aureus enzyme was solved by molecular replace-
ment in Phaser[42] using the structure of H. influenza NAL (PDB ID:
1F74)[30] as the search model and subsequent structures were
solved by direct Fourier methods. REFMAC5[43] was used for refine-
ment of the data and after each refinement cycle model building
was performed in COOT.[44] Coordinates and restraint library files
for the lysine residue covalently bound to a pyruvoyl moiety (HET
code: KPI) were as previously described.[45] Those for the thialysine
side chain (HET code: SLZ) and for the thialysine covalently bound
to pyruvate (HET code: KPY) were generated using the PRODRG
server and were manually edited. The models were validated using
the PDB validation server.
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